
Sign up to save your podcasts
Or
This subgroup analysis from the MASTER-DAPT trial demonstrates that in high-bleeding risk patients with acute or recent myocardial infarction it is safe to stop DAPT 1 month after stenting and that this strategy provides a reduction in bleeding risk.
In this interview, Pieter C. Smits MD, PhD, FESC and Sidney C. Smith Jr. MD, MACC, with Jeffrey Hsu MD, PhD, discuss a recent piece from JACC: Abbreviated Antiplatelet Therapy after Coronary Stenting in Patients with Myocardial Infarction at High Bleeding Risk.
Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL
3.8
4747 ratings
This subgroup analysis from the MASTER-DAPT trial demonstrates that in high-bleeding risk patients with acute or recent myocardial infarction it is safe to stop DAPT 1 month after stenting and that this strategy provides a reduction in bleeding risk.
In this interview, Pieter C. Smits MD, PhD, FESC and Sidney C. Smith Jr. MD, MACC, with Jeffrey Hsu MD, PhD, discuss a recent piece from JACC: Abbreviated Antiplatelet Therapy after Coronary Stenting in Patients with Myocardial Infarction at High Bleeding Risk.
Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL
130 Listeners
319 Listeners
160 Listeners
862 Listeners
494 Listeners
21 Listeners
32 Listeners
87 Listeners
135 Listeners
1,081 Listeners
39 Listeners
186 Listeners
414 Listeners
35 Listeners
136 Listeners